Associate Professor,
Dr Le Cheng Foh is an Assistant Professor at the School of Biosciences, Faculty of Science, University of Nottingham Malaysia Campus (UNMC). He was a Postdoctoral Research Fellow at the School of Pharmacy, UNMC for three years prior to joining the Faculty as an academic.
He obtained his PhD from the University of Malaya in 2013 for his research on designing and development of Antimicrobial Peptides (AMPs) as alternative antibiotics against Streptococcus pneumoniae. The significance of his works had been recognised in a number of conferences and symposia. In 2013, Dr Le received the Young Investigator Award in the 9th International Symposium on Antimicrobial Agents and Resistance (ISAAR-9) for his research on the design of a series of novel AMPs which successfully cured the mice from lethal pneumocococal infection. Prior to this, he was awarded the BioInnovation Award during the BioMalaysia 2011 and BioMalaysia 2013. He also won a Silver Medal during the University of Malaya Innovation and Creativity Expo 2010.
Antimicrobial Peptides, Drug Discovery & Design, Bioproduction of AMPs, High Throughput Peptide Biosynthesis, Pneumococcal Vaccine, Pneumococcal Serotype Epidemiology, Antibiotic Resistance
Programme Director, BSc (Hons) Biotechnology
Module convenor for :-
Teaching contribution a number of biotechnology & microbiology related modules.
Dr Le's major interest is on drug discovery using Antimicrobial Peptides (AMPs). Currently, he focuses on the directed evolution and next-generation discovery of AMPs using microbial host expression… read more
Dr Le's major interest is on drug discovery using Antimicrobial Peptides (AMPs). Currently, he focuses on the directed evolution and next-generation discovery of AMPs using microbial host expression systems. The optimised systems will be applied for bioproduction and high-throughput screening and expression of AMP analogues as novel leads. Besides, his research is aligned towards understanding the fundamental principles governing the biological activity of AMPs towards designing therapeutically-enhanced synthetic peptide variants to be used as the novel antimicrobial agents.
He is also working on discovering novel antimicrobial compounds from the natural environments and improving on the qualitative and quantitative aspects of the antimicrobial compounds. A key area of his research interest is pneumococcal vaccination, in particular pneumococcal serotype distribution and antibiotic profiling,
University of Nottingham Malaysia Jalan Broga, 43500 Semenyih Selangor Darul EhsanMalaysia
telephone: +6 (03) 8924 8000 fax: +6 (03) 8924 8001
Make an enquiry
Browser does not support script.